🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 38 of 857 · Phase 3 first, then by program name

  1. CKD-495 75mg

    Hong Kong Baptist University

    Gastritis

    phase 3 small molecule completed

    1 trial

  2. CKD-501 0.5mg

    Hong Kong Baptist University

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    2 trials

  3. CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS, Placebo to Clostridium Botulinum neurotoxin type A (150 kD)

    Merz Therapeutics GmbH

    Episodic migraine

    phase 3 small molecule active

    1 trial

  4. CLS2901C (human [allogeneic] chondrocyte sheets)

    CellSeed Europe Ltd

    Osteoarthritis of the Knee

    phase 3 mab active

    1 trial

  5. CMF regimen

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 small molecule active

    2 trials

  6. CMP-001

    Regeneron UK Limited

    Melanoma

    phase 3 small molecule completed

    3 trials

  7. CMS

    Zambon SpA

    Non Cystic Fibrosis Bronchiectasis

    phase 3 small molecule completed

    1 trial

  8. COAGULATION FACTOR VIII , COAGULATION FACTOR VIIA , COAGULATION FACTOR IX , SAR439774, FACTOR VIII INHIBITOR BYPASSING ACTIVITY , ANTITHROMBIN III

    Genzyme Europe B.V.

    Hemophilia A or Hemophilia B

    phase 3 small molecule active

    1 trial

  9. COBALAMIN

    The George Institute

    Hydroxycobalamin deficiency

    phase 3 small molecule active

    1 trial

  10. COBI

    Gilead Sciences Ireland UC

    HIV

    phase 3 small molecule completed

    1 trial

  11. COLCHICINE OPOCALCIUM 1 mg, comprimé sécable

    Pari Pharma GmbH

    Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial Infarction, Coronary Syndrome, Cerebral Infarction

    phase 3 small molecule active

    1 trial

  12. COLECALCIFEROL , PREDNISONE

    Fondazione Telethon ETS

    Elderly patients with Diffuse Large B-Cell Lymphoma (DLBCL)

    phase 3 small molecule active

    1 trial

  13. COMP360 psilocybin

    Compass Therapeutics

    PTSD - Post Traumatic Stress Disorder

    phase 3 small molecule active

    1 trial

  14. CONDROSULF 800 mg tabletta

    The George Institute

    Knee osteoarthritis with moderate to severe pain

    phase 3 small molecule active

    1 trial

  15. CONOXIA, gas medicinal comprimido, Conoxia 100% medicinal gas, cryogenic

    The George Institute

    ILD

    phase 3 small molecule active

    1 trial

  16. COPINAL 300 mg cápsulas, Placebo has the same composition than imp except the active substance

    The George Institute

    Chronic liver disease

    phase 3 small molecule active

    1 trial

  17. CORTANCYL 20 mg, comprimé sécable, Placebo of CORTANCYL 20 mg

    Pari Pharma GmbH

    Adults patients with isolated acute urticaria presenting to the emergency department

    phase 3 small molecule active

    1 trial

  18. CORTANCYL 20 mg, comprimé sécable, placebo of Cortancyl 20 mg, NaCl 0,9% as placebo of kineret, Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe.

    Pari Pharma GmbH

    Men and women over 18 years of age with renal failure renal failure stages 3b/4/5, renal transplantation or dialysis and an untreated gout attack

    phase 3 small molecule active

    1 trial

  19. COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab completed

    1 trial

  20. COVID-19 Vaccine,Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab completed

    1 trial

  21. CP 751,871 (Figitumumab)

    Pfizer

    Carcinoma, Large Cell

    phase 3 small molecule terminated

    1 trial

  22. CP-690,550

    Pfizer

    Arthritis, Rheumatoid

    phase 3 small molecule completed

    3 trials

  23. CP101

    Finch Therapeutics Group

    Recurrent C. Difficile Infection

    phase 3 mab terminated

    1 trial

  24. CPI-006 2 mg/kg + SOC

    Corvus Pharmaceuticals

    Covid-19

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources